ArticleFrontiers in pharmacology2018
Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project.
Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets.Chemical research in toxicology · 2025Article
- Identifying Differences in the Performance of Machine Learning Models for Off-Targets Trained on Publicly Available and Proprietary Data Sets.Chemical research in toxicology · 2023Article
- Using Jupyter Notebooks for re-training machine learning models.Journal of cheminformatics · 2022Article
- eTRANSAFE: Building a sustainable framework to share reproducible drug safety knowledge with the public domain.F1000Research · 2022Article
- Assessing the calibration in toxicological in vitro models with conformal prediction.Journal of cheminformatics · 2021Article
- Flame: an open source framework for model development, hosting, and usage in production environments.Journal of cheminformatics · 2021Article
- Crowdsourcing and open innovation in drug discovery: recent contributions and future directions.Drug discovery today · 2020Review
- Unlocking the potential ofComputational toxicology (Amsterdam, Netherlands) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.